{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Hennessee I"],"funding":["National Institute of Neurological Disorders and Stroke","NINDS NIH HHS","National Institutes of Health","NIH HHS"],"pagination":["364-366"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11848264"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["80(2)"],"pubmed_abstract":["In a commercial claims database analysis, <0.5% of patients with inflammatory bowel disease or rheumatoid arthritis developed an invasive fungal infection (IFI) within 1 year of initiating tumor necrosis factor-alpha therapy. Histoplasmosis was the most common IFI type. Overall IFI incidence varied based on region, underlying conditions, and use of certain immunosuppressive medications."],"journal":["Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"],"pubmed_title":["Incidence and Risk Factors for Invasive Fungal Infections in Patients Initiating Tumor Necrosis Factor-Alpha Inhibitors for Inflammatory Bowel Disease and Rheumatoid Arthritis."],"pmcid":["PMC11848264"],"funding_grant_id":["K23 NS110470"],"pubmed_authors":["Bahr NC","Gold JAW","Lipner SR","Hennessee I","Benedict K"],"additional_accession":[]},"is_claimable":false,"name":"Incidence and Risk Factors for Invasive Fungal Infections in Patients Initiating Tumor Necrosis Factor-Alpha Inhibitors for Inflammatory Bowel Disease and Rheumatoid Arthritis.","description":"In a commercial claims database analysis, <0.5% of patients with inflammatory bowel disease or rheumatoid arthritis developed an invasive fungal infection (IFI) within 1 year of initiating tumor necrosis factor-alpha therapy. Histoplasmosis was the most common IFI type. Overall IFI incidence varied based on region, underlying conditions, and use of certain immunosuppressive medications.","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Feb","modification":"2025-04-04T09:10:00.091Z","creation":"2025-04-04T09:10:00.091Z"},"accession":"S-EPMC11848264","cross_references":{"pubmed":["39223720"],"doi":["10.1093/cid/ciae444"]}}